Literature DB >> 14581560

Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.

Michael Nickells1, Thomas J Chambers.   

Abstract

A molecular clone of mouse-neuroadapted yellow fever 17D virus (SPYF-MN) was used to identify critical determinants of viral neuroinvasiveness in a SCID mouse model. Virus derived from this clone differs from nonneuroinvasive YF5.2iv virus at 29 nucleotide positions, encoding 13 predicted amino acid substitutions and 2 substitutions in the 3' untranslated region (UTR). The virulence determinants of SPYF-MN for SCID mice were identified by constructing and characterizing intratypic viruses in which the E protein of SPYF-MN was expressed in the YF5.2iv background (SPYF-E) or the E protein of YF5.2iv was expressed in the SPYF-MN background (YF5.2-E). SPYF-E caused lethal encephalitis in young adult SCID mice after intraperitoneal inoculation, with average survival times and tissue virus burdens resembling those of mice inoculated with the parental SPYF-MN virus. To define which domains of the E protein are involved in neuroinvasiveness, two viruses were tested in which the amino acid substitutions in domains I-II and III were segregated. This revealed that substitutions in domain III (residues 305, 326, and 380) were critical for the neuroinvasive phenotype, based on average survival times and tissue burdens of infectious virus. Comparison of growth properties of the various intratypic viruses in cell culture indicated that no inherent defects in replication efficiency were likely to account for the biological differences observed in these experiments. These findings demonstrate that the E protein is a critical factor for yellow fever virus neuropathogenesis in the SCID mouse model and that the neuroinvasive properties depend principally on functions contributed by domain III of this protein. To assess whether critical determinants for neuroinvasion of normal ICR mice by SPYF virus were also in the E protein, sequences of viruses recovered from brains of ICR mice succumbing to encephalitis with the parental SPYF virus were derived. No differences were found in the E protein; however, two substitutions were present in the 3' UTR compared to that of SPYF-MN, one of which is predicted to alter RNA secondary structure in this region. These findings suggest that the 3' UTR may also affect neuroinvasiveness of SPYF virus in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581560      PMCID: PMC254278          DOI: 10.1128/jvi.77.22.12232-12242.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

Authors:  S Bhardwaj; M Holbrook; R E Shope; A D Barrett; S J Watowich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

4.  Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.

Authors:  M Lobigs; R Usha; A Nestorowicz; I D Marshall; R C Weir; L Dalgarno
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

5.  Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Neuroblastoma cell-adapted yellow fever 17D virus: characterization of a viral variant associated with persistent infection and decreased virus spread.

Authors:  Leonsia A Vlaycheva; Thomas J Chambers
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus.

Authors:  Raphaële Germi; Jean-Marc Crance; Daniel Garin; Josette Guimet; Hugues Lortat-Jacob; Rob W H Ruigrok; Jean-Pierre Zarski; Emmanuel Drouet
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

8.  The in vivo differentiation of strains of yellow fever virus in mice.

Authors:  R Fitzgeorge; C J Bradish
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

9.  Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus.

Authors:  F Liprandi
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Comparison of neurovirulence of different strains of yellow fever virus in mice.

Authors:  A D Barrett; E A Gould
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

View more
  14 in total

1.  West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

Authors:  Guido van Marle; Joseph Antony; Heather Ostermann; Christopher Dunham; Tracey Hunt; William Halliday; Ferdinand Maingat; Matt D Urbanowski; Tom Hobman; James Peeling; Christopher Power
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Genetic determinants of Sindbis virus mosquito infection are associated with a highly conserved alphavirus and flavivirus envelope sequence.

Authors:  Dennis J Pierro; Erik L Powers; Ken E Olson
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

3.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970

4.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

5.  Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.

Authors:  Janice Nickells; Maria Cannella; Deborah A Droll; Yan Liang; William S M Wold; Thomas J Chambers
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Characterization of a small plaque variant of West Nile virus isolated in New York in 2000.

Authors:  Yongqing Jia; Robin M Moudy; Alan P Dupuis; Kiet A Ngo; Joseph G Maffei; Greta V S Jerzak; Mary A Franke; Elizabeth B Kauffman; Laura D Kramer
Journal:  Virology       Date:  2007-07-06       Impact factor: 3.616

7.  Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.

Authors:  Young-In Kim; Ryan Murphy; Sirshendu Majumdar; Lisa G Harrison; Jody Aitken; John P DeVincenzo
Journal:  Pediatr Res       Date:  2015-06-24       Impact factor: 3.756

8.  Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.

Authors:  Nathalie Charlier; Richard Molenkamp; Pieter Leyssen; Jan Paeshuyse; Christian Drosten; Marcus Panning; Erik De Clercq; Peter J Bredenbeek; Johan Neyts
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses.

Authors:  Cécile Beck; Philippe Desprès; Sylvie Paulous; Jessica Vanhomwegen; Steeve Lowenski; Norbert Nowotny; Benoit Durand; Annabelle Garnier; Sandra Blaise-Boisseau; Edouard Guitton; Takashi Yamanaka; Stéphan Zientara; Sylvie Lecollinet
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

Review 10.  The key amino acids of E protein involved in early flavivirus infection: viral entry.

Authors:  Tao Hu; Zhen Wu; Shaoxiong Wu; Shun Chen; Anchun Cheng
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.